NCT02707952View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

November 14, 2016

Study Completion Date

February 9, 2017

Conditions
Chronic Hepatitis C VirusHepatitis C Virus
Interventions
DRUG

ABT-493/ABT-530

Co-formulated tablet

DRUG

OBV/PTV/r

Co-formulated tablet

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY